Cargando…
Economic evaluation in genomic medicine /
Economic Evaluation in Genomic Medicine introduces health economics and economic evaluation to genomic clinicians and researchers, while also introducing the topic to health economists. Each chapter includes an executive summary, questions, and case studies, along with supplementary online materials...
| Clasificación: | Libro Electrónico |
|---|---|
| Autores principales: | , , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London :
Academic Press, an imprint of Elsevier,
[2015]
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Front Cover; Economic Evaluation in Genomic Medicine; Copyright Page; Contents; Preface; 1 Economic Evaluation in Health Care: Evidence-Based Medicine and Evidence-Based Health Economics; The Scope of Economic Evaluation of Health Services: The Science of Economics; Evidence-Based Medicine and Evidence-Based Health Economics; The Necessity of Drafting Economic Evaluations; References; 2 Genomic Medicine Today: An Introduction for Health Economists; Introduction; Pharmacogenomics and Genomic Medicine; Applications of Pharmacogenomics; Oncology Examples; Cardiology Examples.
- Psychiatric ExamplesInfectious Disease Examples; Facing the Current Challenges of Genomic Medicine; Education of Health Professionals; Demonstration of Clinical Utility; Health Care Costs; Insurance and Privacy Issues; Conclusions and Future Perspectives; References; 3 Economic Evaluation and Genomic Medicine: What Can They Learn from Each Other?; Introduction; Genomics in Health Economics; Triangulating Genomics with Health Technology Assessment and Health Economics; Economic Evaluation in the Postgenomic Era; References; 4 Introduction to the Technical Issues of Economic Evaluation.
- Sensitivity AnalysisThe Value of Information and Bayesian Analysis; Conclusions; References; 6 Economic Evaluation in the Genomic Era: Some Examples from the Field; Introduction; Using Pharmacogenomics to Prevent Adverse Events; Balancing Adverse Events and Efficacy; The Disease Makes a Difference; Perspectives on Perspective; Defining Performance Characteristics; Cost-Effectiveness Analysis in Genomic Medicine and the Developing World; Conclusions; References; 7 Special Requirements for Economic Evaluation and Health Technology Assessment in Genomic Medicine; Introduction; Analysis Costs.